When considering the collective findings, the notable correlations between adiponectin levels and MetS indicators such as IR, TG, and BP indicate that ADPQ has the potential to serve as a biomarker for evaluating the presence of MetS and for screening for T2DM or CVD. Here, ADIPOQ is linked to metabolic syndrome.